<DOC>
	<DOCNO>NCT02192645</DOCNO>
	<brief_summary>The purpose study determine whether Sanfujiu effective safe treatment persistent allergic rhinitis .</brief_summary>
	<brief_title>The Efficacy Safety Sanfujiu Patients With Persistent Allergic Rhinitis : Randomized Controlled Study</brief_title>
	<detailed_description />
	<mesh_term>Rhinitis , Allergic</mesh_term>
	<mesh_term>Rhinitis</mesh_term>
	<criteria>age ≥18 PAR , define clinically symptoms present least 4 day week , least 4 week Test positive allergen specific immunoglobulin E . Allergens include : mite ( Dermatophagoides pteronyssinus Dermatophagoides farinae ) , cockroach ( Blatella germanica ) and/or house dust Informed consent TNSS ≥3 Seasonal chronic instance form rhinitis ( i.e . sinusitis ) Asthma and/or moderate severe atopic dermatitis Allergy treatment present due asthma , eczema , atopic dermatitis , diseases Nasal structural abnormality Severe mental illness , severe chronic respiratory disease , severe disease cardiovascular system , severe kidney disease , severe liver disease , severe blood system diseases , severe neurological neuromuscular disease , severe metabolic endocrine system disease , severe diabetes , immune function ( include application immunosuppressant HIV infection low immune function etc . ) ; The laboratory test index twice upper limit normal reference value abnormal result n't fit study confirm researcher ; Blood coagulation dysfunction patient use anticoagulant Systemic corticosteroid treatment six month start study , intranasal corticosteroid 15 day start study ; Immunotherapy 3 year ; Alternative therapy acupuncture , traditional Chinese medicine ( TCM ) one month start study , prepare use study ; Moxibustion therapy half year start study ; Patients participate clinical trial ; Prepare pregnancy , pregnancy lactation</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2016</verification_date>
</DOC>